• News
  • SAN DIEGO
  • Medical

Adamis files new drug application with FDA

San Diego-based Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration for its epinephrine pre-filled single dose syringe (PFS) product.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Adamis Pharmaceuticals Corp.

Company Website

11455 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ADMP
5.45
  -0.04  
- 0.73%
64,356,000
7.25
2.62

Adamis Pharmaceuticals Corp. Executive(s):

Dennis Carlo

  • Chief Executive Officer, President

Robert Hopkins

  • Chief Financial Officer

Similar Companies

NAICS - 325620 - Toilet Preparation Manufacturing
SIC - 2844 - PERFUMES, COSMETICS, AND OTHER TOILET PREPARATIONS
NAICS - 339112 - Surgical and Medical Instrument Manufacturing
SIC - 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
SIC - 3829 - MEASURING AND CONTROLLING DEVICES, NOT ELSEWHERE CLASSIFIED
Subscribe Today!